Key facts
- Notable investors include Malaysian Technology Development Corporation.
- Status: Privately Held (backing).
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Oncode Scientific
- ·The full record, as it builds
Funding rounds
No funding rounds for Oncode Scientific are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oncode Scientific
Operator of a precision medicine and health deep-tech company driving innovation in diagnostics, research, and patient care across Asia and beyond. The company's platform includes tissue and liquid biopsy testing, single-gene and multi-gene panels using PCR and Next Generation Sequencing technologies, and specialized assays for mutation, fusion, and expression analysis, enabling healthcare professionals and research institutions to access high-resolution genetic data that informs personalized treatment strategies, improves diagnostic accuracy, and supports targeted therapy development.
- Sector
- Healthcare
- HQ
- Shah Alam, Malaysia
- Founded
- 2015
- Employees
- 50
- Website
- oncodesc.com/
- Ownership
- Privately Held (backing)
Oncode Scientific doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oncode Scientific shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oncode Scientific in its N-PORT filings yet. We sweep new filings monthly.